Perspectiva de género en problemas asociados a medicamentos de alto riesgo atendidos en urgencias

Secular Trends in the Use of Valproate-Containing Medicines in Women of Childbearing Age in Europe: A Multinational DARWIN EU Network Study

Detection of Illicit Content on Online Marketplaces using Large Language Models

Adverse events and potential herb-drug interactions of plants used for psoriasis: A systematic review

Is intramuscular adrenaline used promptly against drug-induced anaphylaxis? A perspective from recent analyses of fatal cases in Japan

Relationship Between Trimethoprim-Sulfamethoxazole-Induced Hepatotoxicity and Cytochrome Protein 450 2C9 Using Food and Drug Administration Adverse Event Reporting System Database

Counterfeit Medicines in Informal Retail: A Governance and Complexity Perspective from South African Spaza Shops

Precision Pharmacotherapy and the Artificial Intelligence Revolution in the Neonatal Intensive Care Unit: Developmental Pharmacology, Drug Safety, and Generative Redesign

ChatGPT as a Tool for Perioperative Safety: Evaluating Drug Interaction Detection in Anesthetic Regimens

PERFIL EPIDEMIOLÓGICO E CLÍNICO DAS NOTIFICAÇÕES RELACIONADAS AOS EVENTOS ADVERSOS À TOXINA BOTULÍNICA NO BRASIL: UMA ANÁLISE DE DADOS DO VIGIMED (2018–2025)

Disproportionality Analysis and Timing of Drug-Induced Guillain–Barré Syndrome Onset Based on the Japanese Adverse Drug Adverse Event Report Database

Prevalence of potentially inappropriate medication prescribing, inappropriate medication use, prescription omission and drug interactions among older adults in Ethiopia: a systematic review and meta-analysis

Managing High‐Risk Drug Interactions With Nirmatrelvir/Ritonavir: Experience From a Dedicated Pharmacology Advice Service

AI-Driven ADE: Detection and Clinician-Readable Explanation of Adverse Drug Events in Open Clinical

Exploring Drug Safety Through Knowledge Graphs: Protein Kinase Inhibitors as a Case Study

Radiation medicine and sustainable networks for global health and safety: institutional progress and perspectives from KIRAMS

Antiepileptic Drug-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Case Series

The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database

A real-world pharmacovigilance study of bempedoic acid plus ezetimibe fixed-dose combination based on the FDA FAERS database

Precautionary recall of blood pressure medication after packaging error

Polypharmacy Guidance: appropriate prescribing, making medicines safe, effective and sustainable 2026 – 2029

Primera reunión de 2026 del Comité de Seguridad de Medicamentos Veterinarios y del Comité Técnico del Sistema Español de Farmacovigilancia de Medicamentos Veterinarios

PAHO calls for strengthened pharmacovigilance following reports of misuse of GLP-1 medicines indicated for treating obesity in adults

Quantification and reduction of the health sector’s environmental impact

Counterfeit weight loss products claiming to contain GLP-1

Alerta Epidemiológica: Uso indebido de medicamentos agonistas del receptor GLP-1 y sus consideraciones para la Región de las Américas

Stakeholder Perceptions on Innovative Private Pharmacy Distribution Channels and Implications for Medicine Quality in Zambia: A Qualitative Study

Systematic Pharmacovigilance and Genetic Validation of Medications Associated With Organizing Pneumonia: Integrating FAERS Data With Multiomics Analysis

Artificial intelligence revolution in toxicology: Clinical precision, global equity, and the 2030 roadmap

INTERGENERATIONAL TRANSMISSION OF SMUGGLING AS A PROFESSION

New Deprescribing Guidance Marks an ‘Important Moment’ in Psychiatry

Alteraciones del metabolismo lipídico inducidas por fármacos: un análisis exploratorio de farmacovigilancia del mundo real basado en el sistema de notificación de eventos adversos de la FDA de EE. UU. (FAERS)

Drug-induced Aseptic Meningitis: Pharmacovigilance Analysis of Japanese Adverse Event Reporting Database

Prescription Monitoring Program Review Among Patients with Cancer Receiving Opioids at a Safety-Net Palliative Medicine Clinic

Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System

Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024

Automated dispensing cabinets and nurse-related medication errors in inpatient settings: A systematic review

MHRA Warns of Rare Severe Pancreatitis With GLP-1 Drugs

Toward Integrative Predictive Toxicology: Advanced Methods for Drug Toxicity and Safety Prediction

FDA Regulatory Failures in Enforcing Limits on GLP-1 Compounding Puts Patients at Risk